Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Evaluation of the Safety and Clinical Utility of the Active, Separated System With Enhanced Controller (SSEC) Fentanyl 40 mcg for the Management of Acute Postoperative Pain in Pediatric Patients 12 to Less Than 18 Years of Age

NCT02395653 is registered in ClinicalTrials.gov with The Medicines Company as lead sponsor.

NCT NCT02395653
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02395653 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Evaluation of the Safety and Clinical Utility of the Active, Separated System With Enhanced Controller (SSEC) Fentanyl 40 mcg for the Management of Acute Postoperative Pain in Pediatric Patients 12 to Less Than 18 Years of Age
Lead sponsor
The Medicines Company
Phase
Phase 3
Overall status
Completed
Start date
June 29, 2015
Completion date
September 12, 2016
Enrollment
71 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

pain, postoperative